Navigation Links
Strides Made in Hemophilia Research
Date:6/16/2009

Successful blood-clotting in lab could pave way for human trials, researchers say

TUESDAY, June 16 (HealthDay News) -- Researchers studying the bleeding disease hemophilia in mice have increased the rodents' ability to produce a crucial blood-clotting protein, a new study says. Their success may pave the way for human trials.

Past studies have successfully introduced a gene into animals' cells to make the clotting protein, Factor VIII, which is missing in people with hemophilia. But attempts at gene therapy in humans have been disappointing, the study authors note.

In the new study, the researchers say they have developed an approach to target genes in mouse liver sinusoidal endothelial cells, which are the main source of Factor VIII.

Researchers hope the new approach will be a step toward successful human clinical trials in individuals with hemophilia A, the most common form of the inherited disorder.

The study by researchers from the University of Minnesota Medical School in Minneapolis is in the June issue of the Journal of Clinical Investigation.

In the study, researchers used nanoparticles coated with hyaluron to target liver sinusoidal endothelial cells. The nanoparticles contained a therapeutic gene (Factor VIII) as well as Sleeping Beauty, a genetic element that helps the therapeutic gene become inserted into the genome of the targeted cells.

Fifty weeks after the treatment, mice injected with these nanoparticles had Factor VIII levels that were the same as those of normal mice. Bleeding times were also similar to those of normal mice.

According to a news release from the journal, it is the authors hope that the combination of Sleeping Beauty and the cell-specific nanocapsule delivery system will result in a successful gene therapy.

More information

The National Heart, Lung and Blood Institute has more on hemophilia.



-- Jennifer Thomas



SOURCE: Journal of Clinical Investigation, news release, June 8, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Twenty-Five Individuals Honored by Yoplait(R) for Making Extraordinary Strides in the Fight Against Breast Cancer
2. GREAT STRIDES Walks for Cystic Fibrosis Slated for 47 States This Weekend
3. Gentiva Safe Strides(R) Home Balance Therapy Program is Reducing Risk of Dangerous Falls and Relieving Pain for Thousands of Older Americans
4. Stroller Strides(R) Franchises Succeed Despite Economic Climate
5. Stroller Strides(R) Signs Pampers(R) as Premier Sponsor for 2009
6. Womans Day Presents the Sixth Annual Red Dress Awards Honoring Women Making Strides in the Fight Against Heart Disease
7. Cystic Fibrosis Foundation Launches GREAT STRIDES Walks Nationwide at 600 Locations
8. Nektar Announces Agreement With Baxter to Develop New PEGylated Therapeutics for Hemophilia
9. Transplanted Liver Lining Cells May Cure Hemophilia
10. Wyeths XYNTHA Approved by FDA for Treatment of Hemophilia A
11. eWorld Companies, Inc. Establishes Strategic Alliance With Hemophilia Foundation of Southern California
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Strides Made in Hemophilia Research
(Date:3/25/2017)... ... 2017 , ... Getting earned media coverage meaningful for Garden Media Group's clients ... the year, Garden Media aims to provide material helpful to clients’ goals and bottom ... client’s key messages to gain coveted media placements, Garden Media wows clients year-round. ...
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... ... from third world countries to hospitals in the United States, it’s a threat ... on the current obstacles facing infection prevention and offers strategies for the healthcare ...
(Date:3/24/2017)... ... ... The iaedp Foundation, the premier provider of educational programs and training standards for eating ... of disordered eating, announced today that the 2017 Symposium set a new attendance record ... countries converged on the Green Valley Resort in Las Vegas. , “We are ...
(Date:3/24/2017)... ... 24, 2017 , ... Northridge dentists, Dr. Michel ... sleep apnea and TMJ at their office. TMJ, or temporomandibular joint disorder, has ... type, is increasingly being treated at dental offices with newly developed procedures and ...
(Date:3/24/2017)... ... March 24, 2017 , ... Empower Brokerage, located ... training and leads programs. , In February, 2017, Empower Brokerage introduced their new ... Partners is designed to teach how to maximize their sales efforts, as well ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... , March 24, 2017 Abdominal Aortic Aneurysm Repair Devices Market was ... 2022, Globally, registering a CAGR of 5.1% from 2016 to 2022. The endovascular stent ... dominate the market during the study period. Continue Reading ... ... ...
(Date:3/24/2017)... 2017 New England Pediatric Device Consortium (NEPDC) ... including funding and in-kind service towards the commercialization of ... "Making blood draws less traumatic for children could ... experience better.  We,re looking forward to working with Velano ... care for the kids we treat," said Ann-Christine ...
(Date:3/24/2017)... Research and Markets has announced the addition of the "Global Wound ... report to their offering. ... The global wound care market was worth $24,482.9 million in 2015 and ... Among the various wound care products type, the advanced wound ... 2015. Among the various applications, surgical wound segment held the largest share ...
Breaking Medicine Technology: